PeptidePedia The community reference

Fmoc chemistry (revision 8)

Old revision·02:37, 16 Sep 2024·SafetySignalSid

This is an old revision of this page, as it stood at 02:37, 16 Sep 2024, saved by SafetySignalSid with the summary add the collapse-temperature point, sourced. It may differ substantially from the current revision, and any error it contains may since have been corrected.
Fmoc chemistry
Temporary groupFluorenylmethyloxycarbonyl (Fmoc), base-labile
Side-chain groupsAcid-labile (tBu, Trt, Pbf)
Deprotection reagentPiperidine in DMF
Final cleavageTrifluoroacetic acid with scavengers
Analytical method infobox · conventions

Fmoc chemistry is the protecting-group scheme that dominates modern solid-phase peptide synthesis. The temporary N-terminal group, fluorenylmethyloxycarbonyl, is removed by base; the side-chain protecting groups are removed by acid. The two are orthogonal, so each can be removed without disturbing the other.[1]

Its predecessor, Boc chemistry, used acid for both and therefore required a much stronger acid for final cleavage — hydrogen fluoride — with the handling requirements that implies. Boc chemistry was the scheme of the original solid-phase method.[2] Orthogonality is what made peptide synthesis a routine operation.[1]

Deprotection is monitored spectrophotometrically: the dibenzofulvene released when Fmoc is removed absorbs strongly, so the extent of each deprotection can be followed in real time. This is one of the few in-process checks available in stepwise synthesis.[1]

The cycle

[edit]

Fmoc is removed with a solution of piperidine in dimethylformamide, which abstracts the fluorenyl proton and triggers elimination. The released dibenzofulvene is trapped by excess piperidine to prevent it alkylating the peptide.[1]

The resin is then washed and the next Fmoc-protected amino acid coupled using an activating reagent. See Peptide coupling reagent. The cycle repeats once per residue.

Side-chain protection uses acid-labile groups: tert-butyl for hydroxyl and carboxyl side chains, trityl for cysteine and asparagine, and sulfonyl-type groups for arginine. All are removed in the final acidic cleavage. See Resin cleavage.[3]

References

  1. ^ a b c d Behrendt R, White P, Offer J. "Advances in Fmoc solid-phase peptide synthesis." Journal of Peptide Science 22(1):4–27 (2016). PMID 26785684.
  2. ^ Merrifield RB. "Solid phase peptide synthesis. I. The synthesis of a tetrapeptide." Journal of the American Chemical Society 85(14):2149–2154 (1963). DOI:10.1021/ja00897a025.
  3. ^ United States Pharmacopeia, General Chapter <1503>, Quality Attributes of Synthetic Peptide Drug Substances.